Whalegun
Home

Gwenn Hansen, Chief Scientific Officer: Nurix Therapeutics NRIX Planned sale · Filed 06/25

Trade details

Type
Planned sale notice
Stock
Nurix Therapeutics NRIX
Person
Gwenn HansenChief Scientific Officer
Planned sale date
26/06/25
Filed
26/06/25

More to sell after $53.5K in 3 months

Nurix Therapeutics trades, last 26 weeks

What else happened in Nurix Therapeutics around then

Filed or reported within 30 days of the trade day · 05/26~07/25

Gwenn Hansen's recent trades

  • Gwenn Hansen

    Planned sale10b5-1 planNurix Therapeutics

    $215.1K

    Filed 08/05

  • Gwenn Hansen

    Planned sale10b5-1 planNurix Therapeutics

    $95.5K

    Filed 08/04

  • Gwenn Hansen

    Sell10b5-1 planNurix Therapeutics

    $107.9K

    Filed 06/25

  • Gwenn Hansen

    SellNurix Therapeutics

    $53.5K

    Filed 04/30

  • Gwenn Hansen

    SellNurix Therapeutics

    $79.5K

    Filed 01/30

Gwenn Hansen, Chief Officer — plans to sell 5,394 sh of Nurix Therapeutics NRIX · $104.1K · around 06/25 · 10b5-1 plan | Whalegun